title: gamma-Pyrone compounds. 5. Synthesis and antiplatelet effects of xanthonoxypropanolamines and related compounds.
abstract: A series of simple xanthonoxypropanolamines and related compounds were synthesized. 3-[3-(Cyclopropylamino)propoxy]-xanthone showed same potent antiplatelet effects as norathyriol tetraacetate on arachidonate-induced aggregation. 3-[3-(Cyclohexylamino)-2-hydroxypropoxy]xanthone showed more potent antiplatelet effects than norathyriol tetraacetate on collagen-induced aggregation. The various amino groups of the oxypropanolamine or oxypropylamine side chains of the synthesized compounds regulated the antiplatelet effects.
authors.affiliation: Natural Products Research Center, Kaohsiung Medical College, Taiwan, R.O.C.
authors.forename: S S
authors.initials: SS
authors.lastname: Liou
authors.forename: C M
authors.initials: CM
authors.lastname: Teng
authors.forename: F N
authors.initials: FN
authors.lastname: Ko
authors.forename: C N
authors.initials: CN
authors.lastname: Lin
mesh_terms: D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D003094:Collagen / Q000037:antagonists & inhibitors / Q000494:pharmacology; D066298:In Vitro Techniques; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology; D011412:Propanolamines / Q000138:chemical synthesis* / Q000494:pharmacology; D011817:Rabbits; D013329:Structure-Activity Relationship; D014966:Xanthenes / Q000138:chemical synthesis* / Q000494:pharmacology
chemical_list: D010975:Platelet Aggregation Inhibitors; D011412:Propanolamines; D014966:Xanthenes; D003094:Collagen; D001241:Aspirin